Sign in
Taking people in United StatesNo phase

MRI-Guided Radiation Placement for Gynecologic Cancers

Tests MRI imaging to guide radiation placement in adults with gynecologic cancers.

Key facts

Who runs it
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Where
Baltimore, United StatesSee the site
Trial code
Registry title
Image-Guided Gynecologic Brachytherapy
Status
Recruiting
People taking part
54 people, planned
Started
15 Dec 2016
Expected to end
Dec 2028
Type of study
Interventional
Treatments tested
  • Image-Guided Brachytherapy
Record updated
18 December 2025

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adult women with gynecologic cancer who can have an internal radiation implant (brachytherapy). MRI is used to guide the implant.

Age
Older than 18 years, up to 100 years.
Sex
Women only.
Disease stage
Confirmed carcinoma of the cervix (stage I-IVA or vaginal recurrence), uterus (stage IIIB with vaginal involvement, inoperable, or vaginal recurrence), vagina (stage I-IVA or vaginal recurrence), vulva (stage I-IVA or recurrence), or urethra (at the treating physician's discretion).
Earlier treatment
People who have had radiation or chemotherapy before can join.

Main reasons for not taking part

  • Uncontrolled other illness, such as active infection, symptomatic heart failure, unstable angina, heart rhythm problems, or conditions that limit following the study
  • Absolute neutrophil count below 500 at enrollment
  • A history of metal in the head or eyes

The registry criteria, word for word

Show all 17 criteriaShow less

Who can take part

  • Participants must have histologically or cytologically confirmed carcinoma. Central pathology review is not required; however, pathology will be reviewed at the SKCCC at Johns Hopkins
  • Site/Stage
  • Any patient eligible for internal implantation without MR guidance will be considered eligible for this protocol. Standard criteria for internal implantation include:
  • Carcinoma of the cervix: Stage I-IVA or vaginal recurrence
  • Carcinoma of the uterus: Stage IIIB (vaginal involvement), inoperable, or vaginal recurrence
  • Carcinoma of the vagina: Stage I-IVA or vaginal recurrence
  • Carcinoma of the vulva: Stage I-IVA or recurrence
  • Carcinoma of the urethra based on treating physician's discretion
  • Patients who have received prior radiation or chemotherapy may be enrolled on this study
  • Age > 18 years. Children do not develop these malignancies and therefore are not considered candidates for this trial
  • Life expectancy of greater than 6 months
  • ECOG performance status of <2 or greater, based on treating physician's discretion
  • MRI of the pelvis or PET-CT within 4 months before registration
  • Ability to understand and the willingness to sign a written informed consent document

Who cannot take part

  • Uncontrolled intercurrent illness including, but not limited to ongoing or active infection, symptomatic congestive heart failure, unstable angina pectoris, cardiac arrhythmia, or psychiatric illness/social situations that would limit compliance with study requirements
  • A history of metal in the head or eyes
  • Absolute neutrophil count < 500 at the time of enrollment

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 100 years old?

Where in United States

  • The SKCCC at Johns HopkinsBaltimore, United StatesContact: Shirl DiPasquale, R.N.Taking people

About the trial

What the trial wants to find out

This research is being done to evaluate multimodality imaging, including magnetic resonance imaging-guided therapy (MRT), as a possible treatment for gynecologic cancers. The therapy takes place in the Department of Radiation Oncology at the Johns Hopkins SKCCC. The purpose of this study is to investigate the ability of MRI to successfully guide the placement of the brachytherapy applicator necessary to treat participants' gynecologic cancer. The Investigators want to see if the use of MRI will do a better job of assessing the tumor at the time of brachytherapy than the routinely used CT scan. The Investigators also want to determine if the use of MRI will enable doctors to reduce the radiation dose received by the body during the process of treating the tumor.

The group in the trial

  • Image-Guided BrachytherapyTreatment being tested

    Magnetic Resonance Imaging (MRI) guided brachytherapy Procedure: Image-Guided Brachytherapy

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
A Clinical Trial To Evaluate Image-Guided Gynecologic Brachytherapy In The MR Simulator Suite
Plain-language title
MRI-Guided Radiation Placement for Gynecologic CancersGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Fit questions
Built from NCT02993900, who can take part
Record updated
18 December 2025